Group One Trading
IMNM icon

Group One Trading’s Immunome IMNM Stock Holding History

Group One Trading’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$42.4K Sell
2,000
-1,100
-35% -$23.5K ﹤0.01% 5499
2026
Q1 		$67.8K Sell
3,100
-5,000
-62% -$111K ﹤0.01% 5037
2025
Q4 		$174K Sell
8,100
-38,700
-83% -$679K ﹤0.01% 4503
2025
Q3 		$548K Buy
46,800
+45,100
+2,653% +$449K ﹤0.01% 3618
2025
Q2 		$15.8K Buy
1,700
+1,300
+325% +$10.7K ﹤0.01% 6422
2025
Q1 		$2.69K Sell
400
-1,700
-81% -$16.3K ﹤0.01% 6895
2024
Q4 		$22.3K Buy
+2,100
New +$25.4K ﹤0.01% 5613
2024
Q3 		– Sell
-900
Closed -$10.9K – 6948
2024
Q2 		$10.9K Sell
900
-4,700
-84% -$73.5K ﹤0.01% 5605
2024
Q1 		$138K Sell
5,600
-7,400
-57% -$150K ﹤0.01% 3861
2023
Q4 		$139K Buy
13,000
+8,200
+171% +$68.2K ﹤0.01% 4189
2023
Q3 		$40.1K Sell
4,800
-6,100
-56% -$44.8K ﹤0.01% 5305
2023
Q2 		$86.2K Buy
10,900
+9,900
+990% +$54.1K ﹤0.01% 4761
2023
Q1 		$4.99K Sell
1,000
-1,500
-60% -$7.34K ﹤0.01% 6280
2022
Q4 		$5.5K Buy
2,500
+1,500
+150% +$6.04K ﹤0.01% 6302
2022
Q3 		$4K Sell
1,000
-2,700
-73% -$12.7K ﹤0.01% 6928
2022
Q2 		$12K Hold
3,700
– – ﹤0.01% 6654
2022
Q1 		$21K Sell
3,700
-11,600
-76% -$86.7K ﹤0.01% 6714
2021
Q4 		$198K Buy
15,300
+600
+4% +$10.7K ﹤0.01% 5093
2021
Q3 		$358K Buy
+14,700
New +$256K ﹤0.01% 4558

Other funds holding IMNM

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return

Group One Trading's IMNM Position: Q2 2026 in Review

Group One Trading opened a new position in Immunome (IMNM) in Q2 2026: 7 shares worth $148. The stake represents ﹤0.01% of the portfolio and ranks #7386 among its holdings. This is a return to the name: Group One Trading previously reported a position in IMNM as recently as Q4 2025.

Group One Trading first reported a position in IMNM in Q2 2022 and has held it in 11 quarters since. The position peaked at $494K in Q4 2025. 203 funds tracked by Wall St. Rank hold IMNM as of Q2 2026.

  • Group One Trading held 7 shares of Immunome worth $148 as of Q2 2026.
  • Immunome was a new Group One Trading position in Q2 2026.
  • Immunome made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #7386 holding.
  • Group One Trading first reported a position in Immunome in Q2 2022 and has held it in 11 quarters since.
  • Group One Trading's Immunome position peaked at $494K in Q4 2025.
  • 203 funds tracked by Wall St. Rank held Immunome as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.